Clinical trials
Completed Phase 4 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
408 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 6 |
| 2002 | 9 |
| 2003 | 14 |
| 2004 | 12 |
| 2005 | 15 |
| 2006 | 20 |
| 2007 | 15 |
| 2008 | 15 |
| 2009 | 21 |
| 2010 | 26 |
| 2011 | 38 |
| 2012 | 17 |
| 2013 | 15 |
| 2014 | 15 |
| 2015 | 22 |
| 2016 | 21 |
| 2017 | 20 |
| 2018 | 11 |
| 2019 | 20 |
| 2020 | 14 |
| 2021 | 12 |
| 2022 | 9 |
| 2023 | 17 |
| 2024 | 13 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 408 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Poznan University of Medical Sciences | 34 |
| Pfizer | 27 |
| Medical University of Warsaw | 22 |
| Novartis Pharmaceuticals | 16 |
| GlaxoSmithKline | 14 |
| Hoffmann-La Roche | 12 |
| Eli Lilly and Company | 11 |
| AstraZeneca | 10 |
| Novo Nordisk A/S | 9 |
| Boehringer Ingelheim | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 26 |
| Diabetes Mellitus | 15 |
| Asthma | 14 |
| Coronary Artery Disease | 12 |
| Postoperative Pain | 12 |
| Pulmonary Disease, Chronic Obstructive | 11 |
| Multiple Sclerosis | 9 |
| Osteoarthritis, Hip | 9 |
| Arthritis, Rheumatoid | 8 |
| Migraine Disorders | 8 |
Trials
Showing 1 to 25 of 408. Each trial links to its page on Pharma Observatory.
308 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.